1. Home
  2. FEMY vs KFFB Comparison

FEMY vs KFFB Comparison

Compare FEMY & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • KFFB
  • Stock Information
  • Founded
  • FEMY 2004
  • KFFB 2005
  • Country
  • FEMY United States
  • KFFB United States
  • Employees
  • FEMY 71
  • KFFB N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • KFFB Savings Institutions
  • Sector
  • FEMY Health Care
  • KFFB Finance
  • Exchange
  • FEMY Nasdaq
  • KFFB Nasdaq
  • Market Cap
  • FEMY 23.1M
  • KFFB 25.9M
  • IPO Year
  • FEMY 2021
  • KFFB 2005
  • Fundamental
  • Price
  • FEMY $0.71
  • KFFB $3.20
  • Analyst Decision
  • FEMY Strong Buy
  • KFFB
  • Analyst Count
  • FEMY 3
  • KFFB 0
  • Target Price
  • FEMY $7.33
  • KFFB N/A
  • AVG Volume (30 Days)
  • FEMY 238.0K
  • KFFB 1.3K
  • Earning Date
  • FEMY 08-08-2025
  • KFFB 09-17-2025
  • Dividend Yield
  • FEMY N/A
  • KFFB N/A
  • EPS Growth
  • FEMY N/A
  • KFFB N/A
  • EPS
  • FEMY N/A
  • KFFB N/A
  • Revenue
  • FEMY $1,887,016.00
  • KFFB $8,308,000.00
  • Revenue This Year
  • FEMY $283.83
  • KFFB N/A
  • Revenue Next Year
  • FEMY $161.03
  • KFFB N/A
  • P/E Ratio
  • FEMY N/A
  • KFFB N/A
  • Revenue Growth
  • FEMY 98.61
  • KFFB 13.79
  • 52 Week Low
  • FEMY $0.69
  • KFFB $1.96
  • 52 Week High
  • FEMY $1.80
  • KFFB $3.62
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 34.99
  • KFFB 56.00
  • Support Level
  • FEMY $0.72
  • KFFB $3.10
  • Resistance Level
  • FEMY $1.00
  • KFFB $3.30
  • Average True Range (ATR)
  • FEMY 0.06
  • KFFB 0.06
  • MACD
  • FEMY -0.01
  • KFFB -0.01
  • Stochastic Oscillator
  • FEMY 0.89
  • KFFB 70.59

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About KFFB Kentucky First Federal Bancorp

Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.

Share on Social Networks: